Suppr超能文献

相似文献

1
Immunotherapy-related adverse effects on F-FDG PET/CT imaging.
Br J Radiol. 2020 Jul;93(1111):20190832. doi: 10.1259/bjr.20190832. Epub 2020 Feb 27.
2
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
J Hepatol. 2018 Jun;68(6):1181-1190. doi: 10.1016/j.jhep.2018.01.033. Epub 2018 Feb 8.
4
Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells.
Front Immunol. 2019 Sep 26;10:2254. doi: 10.3389/fimmu.2019.02254. eCollection 2019.
5
F-FDG PET/CT features of immune-related adverse events and pitfalls following immunotherapy.
J Med Imaging Radiat Oncol. 2022 Jun;66(4):483-494. doi: 10.1111/1754-9485.13390. Epub 2022 Feb 22.
9
Nivolumab Immunotherapy-Related Skin Reactions Detected on 18F-FDG PET/CT in Renal Cell Cancer.
Clin Nucl Med. 2022 Jul 1;47(7):e513-e514. doi: 10.1097/RLU.0000000000004224. Epub 2022 Apr 20.
10
Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.
Am J Clin Dermatol. 2018 Jun;19(3):345-361. doi: 10.1007/s40257-017-0336-3.

引用本文的文献

4
Exploring the Evolution of Breast Cancer Imaging: A Review of Conventional and Emerging Modalities.
Cureus. 2025 Apr 22;17(4):e82762. doi: 10.7759/cureus.82762. eCollection 2025 Apr.
5
Pseudoprogression Shown on F-FDG PET/CT After Pembrolizumab Treatment in a Case of Metastatic Bladder Cancer.
Mol Imaging Radionucl Ther. 2025 Feb 7;34(1):70-72. doi: 10.4274/mirt.galenos.2024.47135.
6
Imaging of tumor-associated macrophage dynamics during immunotherapy using a CD163-specific nanobody-based immunotracer.
Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2409668121. doi: 10.1073/pnas.2409668121. Epub 2024 Dec 18.
8
10
New developments in the imaging of lung cancer.
Breathe (Sheff). 2024 Mar;20(1):230176. doi: 10.1183/20734735.0176-2023. Epub 2024 Apr 9.

本文引用的文献

1
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
N Engl J Med. 2019 Oct 17;381(16):1535-1546. doi: 10.1056/NEJMoa1910836. Epub 2019 Sep 28.
2
Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.
Radiology. 2019 Jan;290(1):9-22. doi: 10.1148/radiol.2018181349. Epub 2018 Nov 20.
3
FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature.
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):238-250. doi: 10.1007/s00259-018-4171-4. Epub 2018 Oct 5.
4
Metformin Discontinuation prior to FDG PET/CT: A Randomized Controlled Study to Compare 24- and 48-hour Bowel Activity.
Radiology. 2018 Nov;289(2):418-425. doi: 10.1148/radiol.2018180078. Epub 2018 Aug 14.
5
Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature.
Gastroenterology Res. 2018 Jun;11(3):174-188. doi: 10.14740/gr1041w. Epub 2018 May 31.
6
The role of interim F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma.
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1289-1296. doi: 10.1007/s00259-018-3972-9. Epub 2018 Feb 24.
7
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small-Cell Lung Cancer.
JAMA Oncol. 2018 Mar 1;4(3):374-378. doi: 10.1001/jamaoncol.2017.2925.
9
Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy.
Curr Radiol Rep. 2016;5(11):59. doi: 10.1007/s40134-017-0256-2. Epub 2017 Sep 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验